| |
| |
|
| Insider
Information: |
Smith Ian F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
267,823 |
|
|
Indirect Shares
|
5,306 |
|
|
| Direct
Value |
$21,537,273 |
|
|
|
Indirect Value
|
$2,338,036 |
|
|
| Total
Shares |
273,129 |
|
|
| Total
Value |
$23,875,308 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
|
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2016-01-04 |
4 |
AS |
$41.85 |
$553,706 |
D/D |
(13,231) |
0 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2018-05-02 |
4 |
AS |
$23.46 |
$237,175 |
D/D |
(10,000) |
0 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2018-06-15 |
4 |
AS |
$31.42 |
$785,568 |
D/D |
(25,000) |
0 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & CFO |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
1,920 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & CFO |
• – – |
2004-03-17 |
4 |
A |
$0.01 |
$29 |
D/D |
2,880 |
4,800 |
|
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2018-05-02 |
4 |
OE |
$20.16 |
$201,600 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2016-01-04 |
4 |
OE |
$17.85 |
$242,093 |
D/D |
13,231 |
13,231 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2012-11-16 |
4 |
AS |
$41.26 |
$249,293 |
D/D |
(6,042) |
18,126 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2012-01-19 |
4 |
AS |
$37.00 |
$223,554 |
D/D |
(6,042) |
21,751 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2017-05-25 |
4 |
A |
$1.74 |
$39,999 |
D/D |
22,988 |
22,988 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2012-10-08 |
4 |
AS |
$60.00 |
$2,687,220 |
D/D |
(44,787) |
24,168 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2012-10-11 |
4 |
AS |
$60.00 |
$842,580 |
D/D |
(14,043) |
24,168 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2013-04-19 |
4 |
AS |
$81.50 |
$60,963,612 |
D/D |
(745,685) |
24,168 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2013-05-15 |
4 |
AS |
$79.51 |
$48,521 |
D/D |
(609) |
24,168 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2018-06-15 |
4 |
OE |
$13.80 |
$461,500 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-01-25 |
4 |
AS |
$40.71 |
$245,970 |
D/D |
(6,042) |
27,793 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-05-25 |
4 |
AS |
$55.52 |
$676,106 |
D/D |
(12,084) |
27,793 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-11-15 |
4 |
AS |
$29.75 |
$595 |
D/D |
(20) |
27,793 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2013-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
30,210 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-01-21 |
4 |
AS |
$39.93 |
$241,257 |
D/D |
(6,042) |
33,835 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,620 |
37,670 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2012-10-11 |
4 |
OE |
$18.93 |
$341,943 |
D/D |
14,043 |
38,211 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2010-05-18 |
4 |
AS |
$37.68 |
$29,164 |
D/D |
(774) |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2010-11-15 |
4 |
AS |
$34.47 |
$2,654 |
D/D |
(77) |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-02-03 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
39,877 |
0 |
- |
|
128 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
